Looking back: 10 key AI in Healthcare stories from 2019
The free newsletter covering the top headlines in AI
The free newsletter covering the top headlines in AI
Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official generic name by USAN.
Paradromics has formed a strategic partnership with Saudi Arabia’s Neom
Nuance Audio showcased its glasses with built-in hearing aids at CES 2025. Now that the product is FDA-approved, it will be available in the US…
The surge of AI solutions flooding the market, including the recent launch of Deepstack, has drawn the attention of organizations worldwide.
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.
Large language models outperformed neuroscience experts in predicting study outcomes, achieving 81.4% accuracy versus 63.4%. Their success stemmed from superior contextual integration.
Nelly wants to become the biggest fintech startup in the healthcare industry. The Berlin-based startup is already working with more than 1,200 medical
Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous…
State legislators are renewing efforts to regulate the use of artificial intelligence in health insurers’ coverage decisions, fueled in part by the discontent many Americans…
Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.